Trade names from 'oxytocin-vial' to 'octreotide' - Electronic medicinal guide TALKDRUGS

Solution for injection, 5 IU / ml.

VIAL, LLC Russia

Solution for intravenous and intramuscular injection, 5 IU / ml.

Solution for infusion and intramuscular injection, 5 IU / ml.

A solution for intravenous and intramuscular administration, 5 IU / ml.

Spray nasal dosed, 11.25 mcg / dose and 22.5 mcg / dose.
Tablets of 50 mg.

Ointment nasal 0,2500%.

OZONE, LLC Russia

Ointment nasal 0,25%.

Ointment nasal 0,25%.
Ointment for external use 3%.
Ointment for topical application 0,25%.
Ointment nasal 0,25%.
Ointment nasal, 0,25%.
Ointment for external use, 3%.

Ointment nasal, 0,25%.

Ointment nasal 0,25%.
Capsules, 10 mg.

Solution for infusions, 50 mg / ml.

Solution for infusion, 100 mg / ml.

Lyophilizate for solution for infusion, 250 ME, 500 ME and 1000 ME.

Lyophilizate for the preparation of a solution for intravenous administration, 250 ME, 500 ME and 1000 ME.
Lyophilizate for the preparation of a solution for intravenous administration.

Eye drops 6.05%.

SIIFI SpA Italy
Concentrate for the preparation of a solution for infusions of 30 mg / ml.
Capsules of 300 mg.
Film-coated tablets, 600 mg.
Lyophilizate for the preparation of a solution for intravenous administration 250 ME, 500 ME, 1000 ME or 2000 ME.

Solution for intravenous and subcutaneous administration, 50 μg / ml, 100 μg / ml, 300 μg / ml.

NATIVA, LLC Russia

Solution for intravenous and subcutaneous administration, 50, 100 μg / ml.

Solution for intravenous and subcutaneous administration, 50, 100 μg / ml.

Solution for intravenous and subcutaneous administration, 300, 600 μg / ml.

Liofilizate for cooking solution for intravenous administration.

Solution for intravenous and subcutaneous administration, 50 μg / ml, 100 μg / ml.

Solution for intravenous and subcutaneous administration, 50, 100 μg / ml.